Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
117 studies found for:    SRT501
Show Display Options
Rank Status Study
1 Completed A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
Condition: Neoplasms, Colorectal
Interventions: Drug: Placebo;   Drug: SRT501
2 Terminated A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: 5.0g SRT501;   Drug: Bortezomib
3 Completed Effects of Resveratrol in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Trans-resveratrol extract from Polygonum Cuspidatum;   Drug: Placebo
4 Recruiting Long-term Resveratrol and Metabolism
Condition: Pre-diabetes
Interventions: Dietary Supplement: resveratrol;   Dietary Supplement: placebo
5 Unknown  Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients
Conditions: Androgen Profile;   Inflammatory Markers;   IVF Outcome
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo pills
6 Completed Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Resveratrol
7 Recruiting Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo
8 Completed Resveratrol for Patients With Colon Cancer
Conditions: Colon Cancer;   Cancer
Intervention: Drug: Resveratrol
9 Active, not recruiting A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
Condition: Neuroendocrine Tumor
Intervention: Dietary Supplement: Resveratrol
10 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
11 Completed Resveratrol and Serum Apo A-I
Condition: Dyslipidemia
Intervention: Dietary Supplement: Resveratrol capsules
12 Unknown  Resveratrol and Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
13 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
14 Completed
Has Results
The Cognitive and Cerebral Blood Flow Effects of Resveratrol
Condition: Cognitive and Cerebral Blood Flow Effects of Resveratrol
Interventions: Dietary Supplement: Trans- resveratrol;   Other: Placebo (silica)
15 Recruiting Resveratrol: a Potential Anti-remodeling Agent in Heart Failure, From Bench to Bedside
Condition: Non-ischemic Cardiomyopathy
Interventions: Other: Resveratrol;   Other: Placebo
16 Recruiting Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Resveratrol;   Drug: Placebo
17 Completed Effects of High-Dose Resveratrol in Non-Diabetic Obese Males
Conditions: Obesity;   Diabetes
Interventions: Drug: Resveratrol;   Drug: Placebo
18 Completed Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol
Conditions: Dyslipidaemia;   Insulin Resistance
Intervention: Drug: Resveratrol
19 Unknown  Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Condition: Impaired Glucose Tolerance
Interventions: Dietary Supplement: resveratrol;   Drug: Placebo
20 Active, not recruiting Impact of Resveratrol on Brain Function and Structure
Condition: Healthy
Interventions: Dietary Supplement: resveratrol supplementation;   Dietary Supplement: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.